Cencora plans to invest $1 billion through 2030 in its U.S. distribution network, including a second National Distribution Center and expanded specialty capacity.
OneOncology contribution and an easier fourth-quarter expense comparison are expected to support U.S. Healthcare Solutions growth.
World Courier is winning new specialty-logistics contracts in cell and gene therapies and laboratory logistics, supporting international growth.
Cencora is expanding the clinical-trial business across its MSO platform, with OneOncology still in early innings.
Cencora raised fiscal 2026 adjusted EPS guidance to $17.75-$17.95, reflecting continued execution and share repurchases.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Cencora, Inc. and 4,900+ companies.